Disease | cardiomyopathy |
Phenotype | C0013264|duchenne muscular dystrophy |
Sentences | 14 |
PubMedID- 26058601 | cardiomyopathy in duchenne muscular dystrophy: current value of clinical, electrophysiological and imaging findings in children and teenagers. |
PubMedID- 21768542 | Background: nearly universal cardiomyopathy in duchenne muscular dystrophy (dmd) contributes to heart failure and death. |
PubMedID- 22655514 | No consensus exists regarding the proper pharmacologic intervention and timing of treatment for cardiomyopathy in patients with duchenne muscular dystrophy. |
PubMedID- 22266080 | The functional changes observed are comparable to the evolution of dilated cardiomyopathy in duchenne muscular dystrophy, indicating that mdx/utrn(-/-) dystrophin/utrophin-deficient mice are a possible phenotypic model for cardiomyopathy in duchenne muscular dystrophy. |
PubMedID- 24969422 | These findings provide new mechanistic and functional insight into cardiomyopathy associated with duchenne muscular dystrophy. |
PubMedID- 21784508 | This complication was judged most likely to be part of the well described pattern of cardiomyopathy associated with duchenne muscular dystrophy. |
PubMedID- 19943106 | cardiomyopathy in duchenne muscular dystrophy: pathogenesis and therapeutics. |
PubMedID- 21575230 | Background: cardiomyopathy in duchenne muscular dystrophy (dmd) is an increasing cause of death in patients. |
PubMedID- 25554404 | Eplerenone for early cardiomyopathy in duchenne muscular dystrophy: a randomised, double-blind, placebo-controlled trial. |
PubMedID- 23400933 | A dilated cardiomyopathy (dcm) is associated with duchenne muscular dystrophy (dmd). |
PubMedID- 25554403 | Prevention of cardiomyopathy in duchenne muscular dystrophy. |
PubMedID- 23866715 | Oral corticosteroids and onset of cardiomyopathy in duchenne muscular dystrophy. |
PubMedID- 22318092 | Dystrophin-deficient duchenne cardiomyopathy is associated with duchenne muscular dystrophy (dmd), the most common lethal muscular dystrophy. |
PubMedID- 23352781 | Objectives: this study sought to determine the impact of steroid therapy on cardiomyopathy and mortality in patients with duchenne muscular dystrophy (dmd). |
Page: 1